Related Experiment Videos
Chronic otitis media with effusion sequelae in children treated with tubes
Kathleen A Daly1, Lisa L Hunter, Bruce R Lindgren
1University of Minnesota Otitis Media Research Center, University of Minnesota School of Medicine, USA. dalyx002@umn.edu
Archives of Otolaryngology--Head & Neck Surgery
|May 22, 2003
Summary
Middle ear sequelae, including atrophy and abnormal tympanometry, are common in children treated for otitis media with effusion. These conditions persist long-term, potentially leading to ongoing ear issues.
Area of Science:
- Otolaryngology
- Pediatric Audiology
- Middle Ear Disease Research
Background:
- Otitis media with effusion (OME) is a common childhood condition requiring treatment.
- Standard treatment involves tympanostomy tubes, but sequelae can arise.
- Long-term outcomes of OME treatment require further investigation.
Purpose of the Study:
- To determine the incidence and prevalence of middle ear sequelae and abnormal tympanometry in children post-tympanostomy tube insertion for OME.
- To assess the long-term development and progression of these middle ear sequelae.
Main Methods:
- Prospective cohort study of 140 children followed for 8 years.
- Evaluated tympanic membrane sequelae (perforation, atrophy, retraction, myringosclerosis) and tympanometry results (static admittance, peak pressure).
- Standard treatment with tympanostomy tubes was administered.
Main Results:
- Annual incidence of sequelae, particularly atrophy and high static admittance with narrow-peaked tympanograms, increased significantly in the first 5 years.
- Prevalence of most sequelae also rose over time, with few ears remaining unaffected by 8 years.
- Sequelae tended to become bilateral, but concordance between different sequelae was low.
Conclusions:
- While the annual incidence of sequelae decreased with age, cumulative effects led to high prevalence by 8 years.
- Functional and morphologic sequelae are common and may predispose children to future middle ear problems.
- Sequelae development is linked to the active phase of OME, with risk decreasing as children mature.